miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer
- PMID: 26575700
- DOI: 10.3892/ijo.2015.3241
miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer
Erratum in
-
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.Int J Oncol. 2024 Nov;65(5):110. doi: 10.3892/ijo.2024.5698. Epub 2024 Sep 27. Int J Oncol. 2024. PMID: 39329219 Free PMC article.
Abstract
Increasing evidence suggests that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miR‑382 has been observed in various types of cancers. However, the biological function of miRNA-382 in ovarian cancer is still largely unknown. Here, we found miR‑382 was downregulated in human ovarian cancer tissues and cell lines. miR‑382 inhibited ovarian cancer cell proliferation, migration, invasion and the epithelial-mesenchymal transition (EMT). Furthermore, we identified receptor tyrosine kinase orphan receptor 1 (ROR1) as a target of miR‑382, and miR‑382 rescued the promotion effect of ROR1 on migration, invasion and EMT process in SKOV3 and COV434 cells. Collectively, these findings revealed that miR‑382 inhibits migration and invision by targeting ROR1 through regulating EMT in ovarian cancer, and might serve as a tumor suppressor in ovarian cancer.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical